Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SEROTONIN REUPTAKE INHIBITORS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1001 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Matsunaga, H; Kiriike, N; Matsui, T; Iwasaki, Y; Stein, DJ
      Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Smith, SS
      Pre-menstrual steroids

      CELLULAR AND MOLECULAR LIFE SCIENCES
    3. Frolich, J; Wiater, A; Lehmkuhl, G
      Successful treatment of severe parasomnias with paroxetine in a 12-year-old boy

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    4. Flament, MF; Lane, R
      Acute antidepressant response to fluoxetine and sertraline in psychiatric outpatients with psychomotor agitation

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Rittmannsberger, H; Wolfl, H
      Pisa syndrome (pleurothotonus) in a polytoxicomanic patient

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    6. Rahola, JG
      Antidepressants: pharmacological profile and clinical consequences

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    7. Condon, JT
      Premenstrual syndrome in primary care: an update

      PRIMARY CARE PSYCHIATRY
    8. Thornett, A
      Developing models for assessing the cost-effectiveness of antidepressants in primary care

      PRIMARY CARE PSYCHIATRY
    9. Hirose, S
      Restlessness related to SSRI withdrawal

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    10. Wellington, K; Perry, CM
      Venlafaxine extended-release - A review of its use in the management of major depression

      CNS DRUGS
    11. Ninan, PT; Berger, J
      Symptomatic and syndromal anxiety and depression

      DEPRESSION AND ANXIETY
    12. Dunner, DL
      Management of anxiety disorders: The added challenge of comorbidity

      DEPRESSION AND ANXIETY
    13. Ninan, PT
      Recent perspectives on the diagnosis and treatment of generalized anxiety disorder

      AMERICAN JOURNAL OF MANAGED CARE
    14. Baker, AM; Russell, JM; Campbell, JK
      Variance in treatment compliance and costs by antidepressant class: Analysis in an HMO setting

      FORMULARY
    15. Naumann, BD; Silverman, KC; Dixit, R; Faria, EC; Sargent, EV
      Case studies of categorical data-derived adjustment factors

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    16. Brown, GK; Bieling, PJ; Beck, AT; Newman, CF; Levy, SJ
      Cognitive therapy for panic disorder: The impact of medication discontinuation on symptoms

      COGNITIVE AND BEHAVIORAL PRACTICE
    17. Shelton, RC; Tomarken, AJ
      Can recovery from depression be achieved.?

      PSYCHIATRIC SERVICES
    18. Mulsant, BH; Pollock, BG; Nebes, R; Miller, MD; Sweet, RA; Stack, J; Houck, PR; Bensasi, S; Mazumdar, S; Reynolds, CF
      A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    19. Furlan, PM; Kallan, MJ; Ten Have, T; Pollock, BG; Katz, I; Lucki, I
      Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    20. Lavretsky, H; Kumar, A
      Methylphenidate augmentation of citalopram in elderly depressed patients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    21. Lobbezoo, F; van Denderen, RJA; Verheij, JGC; Naeije, M
      Reports of SSRI-associated bruxism in the family physician's office

      JOURNAL OF OROFACIAL PAIN
    22. Hoehns, JD; Fouts, MM; Kelly, MW; Tu, KB
      Sudden cardiac death with clozapine and sertraline combination

      ANNALS OF PHARMACOTHERAPY
    23. Sleath, BL; Rubin, RH; Huston, SA
      Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care

      ANNALS OF PHARMACOTHERAPY
    24. Deamer, RL; Wilson, DR; Clark, DS; Prichard, JG
      Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM(R))

      JOURNAL OF ADDICTIVE DISEASES
    25. Boehm, KE; Morris, EJ; Kip, KT; Karas, B; Grubb, BP
      Diagnosis and management of neurally mediated syncope and related conditions in adolescents

      JOURNAL OF ADOLESCENT HEALTH
    26. Masi, G; Toni, C; Mucci, M; Millepiedi, S; Mata, B; Perugi, G
      Paroxetine in child and adolescent outpatients with panic disorder

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    27. Serebruany, VL; Gurbel, PA; O Connor, CM
      Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

      PHARMACOLOGICAL RESEARCH
    28. Hand, I; Peter, H; Rufer, M
      Combined behavioral and pharmacological treatment for obsessive-compulsivedisorders: Research findings and clinical practice

      VERHALTENSTHERAPIE
    29. Pace-Schott, EF; Gersh, T; Silvestri, R; Stickgold, R; Salzman, C; Hobson, JA
      SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects

      JOURNAL OF SLEEP RESEARCH
    30. Petukhov, PA; Zhang, M; Johnson, KJ; Tella, SR; Kozikowski, AP
      SAR studies of piperidine-based analogues of cocaine. Part 3: Oxadiazoles

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    31. Venault, P; Rudrauf, D; Lepicard, EM; Berthoz, A; Jouvent, R; Chapouthier, G
      Balance control and posture in anxious mice improved by SSRI treatment

      NEUROREPORT
    32. Kivela, SL
      Treatment of depressive disorders in old age

      CURRENT OPINION IN PSYCHIATRY
    33. Davis, MP; Homsi, J
      The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

      SUPPORTIVE CARE IN CANCER
    34. van Marwijk, HWJ; Bijl, D; Ader, HJ; de Haan, M
      Antidepressant prescription for depression in general practice in the Netherlands

      PHARMACY WORLD & SCIENCE
    35. Dazzi, L; Serra, M; Spiga, F; Pisu, MG; Jentsch, JD; Biggio, G
      Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    36. Brosen, K; Naranjo, CA
      Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    37. Martinez, D; Hwang, DR; Mawlawi, O; Slifstein, M; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Huang, YY; Shinn, A; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans

      NEUROPSYCHOPHARMACOLOGY
    38. Hervas, I; Vilaro, MT; Romero, L; Scorza, MC; Mengod, G; Artigas, F
      Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635

      NEUROPSYCHOPHARMACOLOGY
    39. Geller, DA; Hoog, SL; Heiligenstein, JH; Ricardi, RK; Tamura, R; Kluszynski, S; Jacobson, JG
      Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    40. Goulet, M; Miller, GM; Bendor, J; Liu, SH; Meltzer, PC; Madras, BK
      Non-amines, drugs without an amine nitrogen, potently block serotonin transport: Novel antidepressant candidates?

      SYNAPSE
    41. Kirby, D; Ames, D
      Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    42. Ruwe, FJL; Smulders, RA; Kleijn, HJ; Hartmans, HLA; Sitsen, JMA
      Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    43. Hindmarch, I
      Expanding the horizons of depression: beyond the monoamine hypothesis

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    44. Artigas, F
      Limitations to enhancing the speed of onset of antidepressants - Are rapidaction antidepressants possible?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    45. Nemets, B; Fux, M; Levine, J; Belmaker, RH
      Combination of antidepressant drugs: The case of inositol

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    46. Nordeng, H; Lindemann, R; Perminov, KV; Reikvam, A
      Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

      ACTA PAEDIATRICA
    47. Kelly, CB; Cooper, SJ
      Noradrenaline: The forgotten neurotransmitter

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    48. Tennyson, H; Levine, N
      Neurotropic and psychotropic drugs in dermatology

      DERMATOLOGIC CLINICS
    49. Francobandiera, G
      Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    50. Bradford, JMW
      The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    51. Kennedy, SH; Lam, RW; Cohen, NL; Ravindran, AV
      Clinical guidelines for the treatment of depressive disorders IV. Medications and other biological treatments

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    52. Thorpe, L; Whitney, DK; Kutcher, SP; Kennedy, SH
      Clinical guidelines for the treatment of depressive disorders VI. Special populations

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    53. Micallef, J; Blin, O
      Neurobiology and clinical pharmacology of obsessive-compulsive disorder

      CLINICAL NEUROPHARMACOLOGY
    54. Dell'Agnello, G; Ceravolo, R; Nuti, A; Bellini, G; Piccinni, A; D'Avino, C; Dell'Osso, L; Bonuccelli, U
      SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study

      CLINICAL NEUROPHARMACOLOGY
    55. Wieczorek, I; Schulz, C; Jarry, H; Lehnert, H
      The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone

      INTERNATIONAL JOURNAL OF OBESITY
    56. Mitchell, PB
      Therapeutic drug monitoring of psychotropic medications

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    57. McManus, P; Mant, A; Mitchell, P; Birkett, D; Dudley, J
      Co-prescribing of SSRIs and TCAs in Australia: how often does it occur andwho is doing it?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    58. Brunello, N; Davidson, JRT; Deahl, M; Kessler, RC; Mendlewicz, J; Racagni, G; Shalev, AY; Zohar, J
      Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity andsocial consequences, biology and treatment

      NEUROPSYCHOBIOLOGY
    59. Ban, TA
      Pharmacotherapy of depression: a historical analysis

      JOURNAL OF NEURAL TRANSMISSION
    60. Naranjo, CA; Tremblay, LK; Busto, UE
      The role of the brain reward system in depression

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    61. Strik, JJ; Honig, A; Maes, M
      Depression and myocardial infarction: Relationship between heart and mind

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    62. Zhao, QY; Wojcik, MA; Parier, JL; Pesco-Koplowitz, L
      Influence of coadministration of fluoxetine on cisapride pharmacokinetics and QTc intervals in healthy volunteers

      PHARMACOTHERAPY
    63. Rojas-Fernandez, CH; Lanctot, KL; Allen, DD; MacKnight, C
      Pharmacotherapy of behavioral and psychological symptoms of dementia: Timefor a different paradigm?

      PHARMACOTHERAPY
    64. Frank, GK; Kaye, WH; Marcus, MD
      Sertraline in underweight binge eating/purging-type eating disorders: Fivecase reports

      INTERNATIONAL JOURNAL OF EATING DISORDERS
    65. Favaro, A; Friederici, S; Santonastaso, P
      Predictors of sertraline discontinuation syndrome in anorexia nervosa

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    66. Ozdemir, V; Kalow, W; Posner, P; Collins, EJ; Kennedy, JL; Tang, BK; Albers, LJ; Reist, C; Roy, R; Walkes, W; Afra, P
      CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    67. Harvey, AT; Preskorn, SH
      Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    68. Perez, V; Puigdemont, D; Gilaberte, I; Alvarez, E; Artigas, F
      Augmentation of fluoxetine's antidepressant action by pindolol: Analysis of clinical, pharmacokinetic, and methodologic factors

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    69. Zanardi, R; Artigas, F; Moresco, R; Colombo, C; Messa, C; Gobbo, C; Smeraldi, E; Fazio, F
      Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    70. Haddad, PM; Devarajan, S; Dursun, SM
      Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'

      JOURNAL OF PSYCHOPHARMACOLOGY
    71. Bozikas, V; Petrikis, P; Karavatos, A
      Urinary retention caused after fluoxetine-risperidone combination

      JOURNAL OF PSYCHOPHARMACOLOGY
    72. Stein, DJ; Montgomery, SA; Kasper, S; Tanghoj, P
      Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    73. Marazziti, D; Dell'Osso, L; Gemignani, A; Ciapparelli, A; Presta, S; Di Nasso, E; Pfanner, C; Cassano, GB
      Citalopram in refractory obsessive-compulsive disorder: an open study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    74. Barbui, C; Campomori, A; Mezzalira, L; Lopatriello, S; Da Cas, R; Garattini, S
      Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    75. Montgomery, SA
      A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    76. Montgomery, SA; Kasper, S; Stein, DJ; Hedegaard, KB; Lemming, OM
      Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    77. Schweitzer, I
      Does risperidone have a place in the treatment of nonschizophrenic patients?

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    78. Catapano, F; Sperandeo, R; Perris, F; Lanzaro, M; Maj, M
      Insight and resistance in patients with obsessive-compulsive disorder

      PSYCHOPATHOLOGY
    79. Liu, ZQ; Shu, Y; Huang, SL; Wang, LS; He, N; Zhou, HH
      Effects of CYP2C19 genotype and CYP2C9 on fluoxetine N-demethylation in human liver macrosomes

      ACTA PHARMACOLOGICA SINICA
    80. Hemmeter, U; Annen, B; Bischof, R; Bruderlin, U; Hatzinger, M; Rose, U; Holsboer-Trachsler, E
      Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine

      PHARMACOPSYCHIATRY
    81. Laux, G
      Cost-benefit analysis of newer versus older antidepressants - Pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants

      PHARMACOPSYCHIATRY
    82. Morrison, JL; Chien, C; Gruber, N; Rurak, D; Riggs, W
      Fetal behavioural state changes following maternal fluoxetine infusion in sheep

      DEVELOPMENTAL BRAIN RESEARCH
    83. Van der Does, AJW
      The effects of tryptophan depletion on mood and psychiatric symptoms

      JOURNAL OF AFFECTIVE DISORDERS
    84. Baillargeon, J; Black, SA; Contreras, S; Grady, J; Pulvino, J
      Anti-depressant prescribing patterns for prison inmates with depressive disorders

      JOURNAL OF AFFECTIVE DISORDERS
    85. Kupfer, DJ; Frank, E
      The interaction of drug- and psychotherapy in the long-term treatment of depression

      JOURNAL OF AFFECTIVE DISORDERS
    86. Weigmann, H; Gerek, S; Zeisig, A; Muller, M; Hartter, S; Hiemke, C
      Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service

      THERAPEUTIC DRUG MONITORING
    87. de la Torre, BR; Dreher, J; Malevany, L; Bagli, M; Kolbinger, M; Omran, H; Luderitz, B; Rao, ML
      Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

      THERAPEUTIC DRUG MONITORING
    88. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, A
      Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

      THERAPEUTIC DRUG MONITORING
    89. Lundmark, J; Reis, M; Bengtsson, F
      Serum concentrations of fluoxetine in the clinical treatment setting

      THERAPEUTIC DRUG MONITORING
    90. Mamiya, K; Kojima, K; Yukawa, E; Higuchi, S; Ieiri, I; Ninomiya, H; Tashiro, N
      Phenytoin intoxication induced by fluvoxamine

      THERAPEUTIC DRUG MONITORING
    91. Thase, ME; Feighner, JP; Lydiard, RB
      Citalopram treatment of fluoxetine nonresponders

      JOURNAL OF CLINICAL PSYCHIATRY
    92. Rytsala, HJ; Melartin, TK; Leskela, US; Lestela-Mielonen, PS; Sokero, TP; Isometsa, ET
      A record-based analysis of 803 patients treated for depression in psychiatric care

      JOURNAL OF CLINICAL PSYCHIATRY
    93. Silvestri, R; Pace-Schott, EF; Gersh, T; Stickgold, R; Salzman, C; Hobson, JA
      Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: A home-based nightcap evaluation during drug administration and withdrawal

      JOURNAL OF CLINICAL PSYCHIATRY
    94. Nelson, EB; Shah, VN; Welge, JA; Keck, PE
      A placebo-controlled, crossover trial of granisetron in SRI-induced sexualdysfunction

      JOURNAL OF CLINICAL PSYCHIATRY
    95. Henry, C; Sorbara, F; Lacoste, J; Gindre, C; Leboyer, M
      Antidepressant-induced mania in bipolar patients: Identification of risk factors

      JOURNAL OF CLINICAL PSYCHIATRY
    96. Posternak, MA; Zimmerman, M
      Switching versus augmentation: A prospective, naturalistic comparison in depressed, treatment-resistant patients

      JOURNAL OF CLINICAL PSYCHIATRY
    97. Preda, A; MacLean, RW; Mazure, CM; Bowers, MB
      Antidepressant-associated mania and psychosis resulting in psychiatric admissions

      JOURNAL OF CLINICAL PSYCHIATRY
    98. Seedat, S; Stein, DJ; Harvey, BH
      Inositol in the treatment of trichotillomania and compulsive skin picking

      JOURNAL OF CLINICAL PSYCHIATRY
    99. Dunner, DL
      Acute and maintenance treatment of chronic depression

      JOURNAL OF CLINICAL PSYCHIATRY
    100. Blier, P
      Possible neurobiological mechanisms underlying faster onset of antidepressant action

      JOURNAL OF CLINICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 15:09:27